1. Home
  2. SGMT vs RSSS Comparison

SGMT vs RSSS Comparison

Compare SGMT & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • RSSS
  • Stock Information
  • Founded
  • SGMT 2006
  • RSSS 2006
  • Country
  • SGMT United States
  • RSSS United States
  • Employees
  • SGMT N/A
  • RSSS N/A
  • Industry
  • SGMT
  • RSSS Business Services
  • Sector
  • SGMT
  • RSSS Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • RSSS Nasdaq
  • Market Cap
  • SGMT 93.7M
  • RSSS 90.4M
  • IPO Year
  • SGMT 2023
  • RSSS N/A
  • Fundamental
  • Price
  • SGMT $2.52
  • RSSS $2.77
  • Analyst Decision
  • SGMT Buy
  • RSSS Strong Buy
  • Analyst Count
  • SGMT 4
  • RSSS 2
  • Target Price
  • SGMT $24.00
  • RSSS $5.18
  • AVG Volume (30 Days)
  • SGMT 207.8K
  • RSSS 33.0K
  • Earning Date
  • SGMT 08-14-2024
  • RSSS 11-07-2024
  • Dividend Yield
  • SGMT N/A
  • RSSS N/A
  • EPS Growth
  • SGMT N/A
  • RSSS N/A
  • EPS
  • SGMT N/A
  • RSSS N/A
  • Revenue
  • SGMT $2,000,000.00
  • RSSS $42,450,102.00
  • Revenue This Year
  • SGMT N/A
  • RSSS $19.75
  • Revenue Next Year
  • SGMT N/A
  • RSSS $11.74
  • P/E Ratio
  • SGMT N/A
  • RSSS N/A
  • Revenue Growth
  • SGMT N/A
  • RSSS 16.92
  • 52 Week Low
  • SGMT $2.13
  • RSSS $2.17
  • 52 Week High
  • SGMT $20.71
  • RSSS $3.50
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 36.41
  • RSSS 52.61
  • Support Level
  • SGMT $2.91
  • RSSS $2.60
  • Resistance Level
  • SGMT $3.18
  • RSSS $2.84
  • Average True Range (ATR)
  • SGMT 0.21
  • RSSS 0.14
  • MACD
  • SGMT -0.01
  • RSSS -0.01
  • Stochastic Oscillator
  • SGMT 0.00
  • RSSS 62.50

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About RSSS Research Solutions Inc

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

Share on Social Networks: